NEOLIVER is a Horizon Europe research and innovation project developing the world’s first autologous bioprinted liver which will be validated in large animal models.
The ultimate goal of the project is to produce dense, vascularized bioprinted liver constructs suitable for clinical use as an Advance Therapy Medicinal Product (ATMP).
Website of the project: https://neoliver.eu/
Project information: https://cordis.europa.eu/project/id/101191649